Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises

被引:38
作者
Wenger, Lynn D. [1 ]
Kral, Alex H. [1 ]
Bluthenthal, Ricky N. [2 ]
Morris, Terry [1 ]
Ongais, Lee [1 ]
Lambdin, Barrot H. [1 ]
机构
[1] RTI Int, 2150 Shattuck Ave,Suite 800, Berkeley, CA 94704 USA
[2] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA
关键词
Syringe Services Programs; COVID-19; Programmatic Adaptations; Overdose; Prevention; INJECTION-DRUG USERS; UNITED-STATES; EXCHANGE PROGRAMS; HARM REDUCTION; HEPATITIS-C; BUPRENORPHINE TREATMENT; HIV; NALOXONE; PEOPLE; INFECTION;
D O I
10.1016/j.trsl.2021.03.011
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
As COVID-19 accelerated throughout 2020, syringe service programs (SSPs) faced challenges necessitating programmatic adaptations to prevent overdose deaths while simultaneously keeping workers and participants safe from COVID-19. We used qualitative methods to gain an understanding of the social context within which SSPs are operating during the COVID-19 pandemic. We conducted 36 in-depth interviews with program representatives from 18 programs and used the Exploration, Preparation, Implementation, Sustainment (EPIS) implementation framework to guide data analysis. We focused on 3 of the 4 EPIS constructs: Outer context, inner context, and innovation factors. Our data indicate that responding to the pandemic led to innovations in service delivery such as secondary and mail-based distribution, adoption of telemedicine for enrolling participants in medications for opioid use disorder (MOUD) and use of virtual training platforms for overdose prevention. We found high levels of staff and volunteer commitment, which was a cornerstone to the success of these innovations. We observed that many SSPs were short-staffed because of their commitment to safety, and some lost current funding as well as opportunities for future funding. Despite minimal staffing and diminished funding, SSPs innovated at an accelerated pace. To ensure the sustainability of these new approaches, a supportive external context (federal, state, and local policies and funding) is needed to support the development of SSPs' inner contexts (organizational characteristics, characteristics of individuals) and sustainment of the innovations achieved regarding delivery of naloxone and MOUD. (Translational Research 2021; 234:159-173)
引用
收藏
页码:159 / 173
页数:15
相关论文
共 65 条
  • [1] Effectiveness of Structural-Level Needle/Syringe Programs to Reduce HCV and HIV Infection Among People Who Inject Drugs: A Systematic Review
    Abdul-Quader, Abu S.
    Feelemyer, Jonathan
    Modi, Shilpa
    Stein, Ellen S.
    Briceno, Alya
    Semaan, Salaam
    Horvath, Tara
    Kennedy, Gail E.
    Des Jarlais, Don C.
    [J]. AIDS AND BEHAVIOR, 2013, 17 (09) : 2878 - 2892
  • [2] American Medical Association, 2020, ISS BRIEF REP INCR O
  • [3] Consideration of the Aerosol Transmission for COVID-19 and Public Health
    Anderson, Elizabeth L.
    Turnham, Paul
    Griffin, John R.
    Clarke, Chester C.
    [J]. RISK ANALYSIS, 2020, 40 (05) : 902 - 907
  • [4] Description and outcomes of a buprenorphine maintenance treatment program integrated within Prevention Point Philadelphia, an urban syringe exchange program
    Bachhuber, Marcus A.
    Thompson, Cole
    Prybylowski, Ann
    Benitez, Jose
    Mazzella, Silvana
    Barclay, David
    [J]. SUBSTANCE ABUSE, 2018, 39 (02) : 167 - 172
  • [5] Syringe services program (SSP) operational changes during the COVID-19 global outbreak
    Bartholomew, Tyler S.
    Nakamura, Nobuyo
    Metsch, Lisa R.
    Tookes, Hansel E.
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 83
  • [6] Approval of syringe exchange programs in California: Results from a local approach to HIV prevention
    Bluthenthal, Ricky N.
    Heinzerling, Keith G.
    Anderson, Rachel
    Flynn, Neil M.
    Kral, Alex H.
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 98 (02) : 278 - 283
  • [7] Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users
    Bluthenthal, Ricky N.
    Ridgeway, Greg
    Schell, Terry
    Anderson, Rachel
    Flynn, Neil M.
    Kral, Alex H.
    [J]. ADDICTION, 2007, 102 (04) : 638 - 646
  • [8] Syringe exchange as a social movement: A case study of harm reduction in Oakland, California
    Bluthenthal, RN
    [J]. SUBSTANCE USE & MISUSE, 1998, 33 (05) : 1147 - 1171
  • [9] The effect of syringe exchange use on high-risk injection drug users: a cohort study
    Bluthenthal, RN
    Kral, AH
    Gee, L
    Erringer, EA
    Edlin, BR
    [J]. AIDS, 2000, 14 (05) : 605 - 611
  • [10] Bonn M, 2020, J STUD ALCOHOL DRUGS, V81, P556, DOI 10.15288/jsad.2020.81.556